Disruptor Profile: Day Zero Diagnostics, Inc.
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Day Zero Diagnostics Inc. is a medical technology company, which is developing a new class of diagnostics, including whole genome sequencing-based diagnostics, for modernizing the diagnosis and treatment of infectious disease using genome sequencing and machine learning (ML) technologies.
Scope
The report provides information and insights into Day Zero Diagnostics, Inc.'s, including –
– Overview of the company and its product offering
– Detailed insight into its business model, company type and headquarter
– Information on funding
– Biography of top management
Reasons to Buy
– Gain insights into Day Zero Diagnostics Inc.’s business operations.
– Gain insights into fundings
– Gain understanding about its technology focus.
Golden Seeds LLC
TriVentures L.P.
National Institute of Allergies
Infectious Disease (NIAID)
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Technology reports

